BCL2 and cancer: Early studies on drug-mediated effects of NR4A1 demonstrated that many apoptosis-inducing drugs that do not directly bind NR4A1 induce nuclear export of this receptor which subsequently binds to mitochondrial bcl-2 to form a pro-apoptotic complex that disrupts mitochondria in cancer cells, resulting in increased cell death (24, 25).